Humic acid: properties, biological roles and benefits

1) What is humic acid?

1.1 Definition & origin. Humic substances – humic acids, fulvic acids, and humins – originate from the slow decomposition (humification) of plant and microbial matter. They form naturally in soils, peats, composts, sediments, and organic deposits (e.g., leonardite), as well as in certain organo-mineral matrices that give rise to shilajit.

1.2 An "ensemble," not a single molecule. Humic acid corresponds to a heterogeneous mixture of macromolecules/supramolecules (aromatic nuclei, aliphatic chains, carboxyl/phenolic groups). Its composition depends on the source (soil, compost, vermicompost, shilajit), the extraction process (pH, solvents, filtration), and purification.

1.3 Solubility, pH, and size. By convention, humic acid is insoluble in acidic environments (pH < 2) and soluble in neutral/basic environments. Its high molecular weight and organization into supramolecular associations distinguish it from fulvic acid (smaller, soluble at all pH levels).

1.4 In shilajit. Humic fractions (humic + fulvic) coexist with minerals and organic compounds. Humic acid primarily plays a structural/adsorbent role; fulvic acid is often described as a vector (transport of trace elements). For an example of raw material, see quality shilajit.

2) Key properties

2.1 High molecular weight & local action

Due to its size and supramolecular associations, humic acid poorly diffuses through membranes. Its role is primarily local: interactions in the intestinal lumen and at the epithelial barrier.

2.2 pH-dependent solubility

Insoluble at acidic pH (stomach) but soluble in neutral/basic conditions (small intestine): this gradient dictates surface interactions (complex formation, adsorption).

2.3 Chelation, complexation, and adsorption

Carboxyl/phenolic groups bind various cations (Pb, Cd, Cu, Fe, etc.) and interact with toxins (e.g., aflatoxin B1). This results in stable complexes and surface adsorption capable of reducing the bioavailability of these substances. To be distinguished from nanomaterials: for nanoparticles, the literature primarily describes surface interactions (adsorption/coating/agglomeration), rather than strict chelation.

2.4 Buffer capacity & colloids

Humic preparations exhibit amphoteric behavior, antioxidant properties (aromatic nuclei), and a tendency to form colloidal aggregates influencing turbidity and the mucosal interface.

2.5 Analytical indicators (quality)

• Humic/fulvic content: IHSS/ISO methods depending on matrix.
• Trace element profile: ICP-MS for heavy metals (Pb, Cd, Hg, As).
• Organic pollutants: GC-MS/HPLC for PAHs (e.g., benzo[a]pyrene), residual solvents.
• Microbial load: total germs, yeasts/molds, specific pathogens.

3) Potential biological roles

3.1 Reduction of heavy metal absorption

Through chelation/complexation, humic acid can bind Pb, Cd, Hg, As (depending on chemical forms) and reduce their bioavailability in the intestine. Solid data in in vitro/animal studies and environmental literature.

3.2 Toxin adsorption

Several preclinical studies show adsorption of mycotoxins (especially AFB1) and preservation of intestinal barrier integrity. This mechanism is consistent with the aromatic/colloidal nature of humic substances.

3.3 Gut microbiota & mucosa

Small human trials report an increase in certain colonic microbial concentrations without loss of diversity, suggesting a local environmental effect.

3.4 Immunomodulation (caution)

Cellular/animal models describe cytokine modulations (TNF-α, IL-6/IL-10, etc.) and antiviral avenues. Limited clinical extrapolation: no hard endpoints established at this stage.

4) Scientific data: what we know (and what we don't)

4.1 Quick overview. The literature includes in vitro studies (complexation, adsorption), animal studies (intestinal barrier, hepatic parameters), and a few pilot human trials (tolerance, microbiota).

4.2 Examples of studies (simplified).

• Microbiota (45 days, healthy volunteers). A standardized humic preparation increased colonic bacterial concentrations without altering diversity. Favorable tolerance. Limited sample size → results need confirmation.
• Aflatoxin B1. Humic acids adsorb AFB1 and attenuate lesion markers; effect linked to barrier protection and microbiota adjustments (models).
• 90-day toxicology (rat). A purified humic/fulvic preparation shows a high NOAEL at tested doses, with no major signal on target organs.

4.3 "Level of evidence" table.

4.4 Methodological limitations. Variability of preparations (source, extraction), small sample sizes, short duration, absence of blinding/placebo in some studies, difficulty in isolating the effect of humics from other components (e.g., in shilajit).

5) Safety & regulation (EU)

5.1 Regulatory framework. In Europe, health claims must be authorized and listed in the EU Register. To date, there are no specific claims for humic acid.

5.2 Contaminants and compliance. Purity is a priority. Expected controls: heavy metals (Pb, Cd, Hg, As), PAHs (e.g., benzo[a]pyrene), mycotoxins (AFB1, OTA, DON depending on matrix), residual solvents, microbial load. Reference: maximum levels of applicable regulations. Demand a recent COA (ideally per batch) detailing methods and detection limits.

5.3 Interactions & at-risk populations. As a precaution, separate intake by 2–3 hours from medications or sensitive minerals (risk of binding/adsorption). Avoid in pregnant/breastfeeding women and in cases of renal insufficiency, unless medically advised.

6) Choosing a good product: practical guidelines

6.1 Origin & traceability

Specify the source (soils/compost/vermicompost/leonardite/shilajit), the extraction process (pH, solvents, filtration), purification (removal of impurities), and standardization (batch-to-batch consistency).

6.2 Batch analyses (COA)

• Heavy metals: ICP-MS (Pb, Cd, Hg, As).
• PAHs: GC-MS/HPLC (including benzo[a]pyrene).
• Mycotoxins: AFB1, OTA, DON (depending on matrix).
• Residual solvents: compliance with applicable thresholds.
• Microbiology: total germs, yeasts/molds, pathogens.

6.3 Transparency

Prefer brands that publish COAs per batch, a clear batch number, a QR code, and factual usage guide. Customer feedback is available on the customer reviews page.

6.4 Formulation

Humic alone (binding/adsorption focus) or humic + fulvic complex (complementarity with fulvic acid). Avoid unnecessary additions if not desired.

7) Usage advice (general)

7.1 Forms & textures. Capsules, powder, liquid, or integration into a complex (e.g., shilajit). The choice depends on ease of use and the advertised standardization.

7.2 Timing of intake. Often with a large glass of water; many people prefer with a meal (tolerance). Avoid simultaneous association with sensitive medications/minerals.

7.3 Progressiveness & observation. Start low (follow the product label), observe tolerance (digestive, transit), adjust only within the framework of manufacturer recommendations.

8) Humic acid vs. fulvic acid

For a detailed overview of the light fraction (mechanisms, safety, uses), read: fulvic acid: benefits, mechanisms, and safety.

10) References

1. International Humic Substances Society – Humic substances: definitions and resources
2. Swidsinski A. et al. (2017). Impact of humic acids on the colonic microbiome in healthy volunteers.
3. Ecotoxicology and Environmental Safety (2023). Humic acids & aflatoxin B1: adsorption, intestinal barrier and microbiota (in vivo/in vitro models).
4. Toxins (2023). Humic preparations: AFB1 adsorption and intestinal integrity (vermicompost).
5. Toxicology Reports (2020). Toxicological evaluation of a humic/fulvic preparation (NOAEL).